Genomics

Dataset Information

36

Comparative transcriptome analysis of two S. aureus strains with different susceptibilities to mersacidin.


ABSTRACT: The lantibiotic mersacidin is an antimicrobial peptide of 20 amino acids that is produced by Bacillus sp. strain HIL Y-85,54728. Lantibiotics are antibiotics containing nonproteinogenic amino acids like lanthionine and/or 3-methyllanthionine. Mersacidin interferes with cell wall biosynthesis by targeting the peptidoglycan precursor lipid II and inhibits the growth of MRSA and other gram-positive bacteria. Therefore, mersacidin could be a lead substance for the development of new antibacterial agents. The clinical VISA isolates S. aureus 137/93A and its spontaneous mutant S. aureus 137/93G show reduced sensitivity towards mersacidin. This phenotype could not be traced to factors being responsible for vancomycinresistance (i.e. the thickened cell wall). Here, we focussed on the comparative transcriptome analysis of S. aureus 137/93A and S. aureus SG511 (sensitive strain) via full genome S. aureus microarrays to identify genes involved in the reduced sensitivity towards mersacidin. Overall design: In this experiment, the transcriptomes of S. aureus 137/93A and S. aureus SG511 (sensitive strain) should be compared via microarray analysis. To this end, S. aureus 137/93A and S. aureus SG511 were grown without mersacidin to determine the genes which are differently expressed in these strains. Each experiment was performed 2 times including a dye swap resulting in two chips per competitive comparison with the incorporated dye reversed. All hybridizations were done with equal amounts of fluorescence-labeled cDNA probes or picomols of dye.

INSTRUMENT(S): sciTracer Staphylococcus aureus N315 Scienion2005

SUBMITTER: Peter Sass  

PROVIDER: GSE12016 | GEO | 2009-01-17

SECONDARY ACCESSION(S): PRJNA113289

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
GSE12016_RAW.tar Raw
filelist.txt Txt
Items per page:
1 - 2 of 2
altmetric image

Publications

Native graS mutation supports the susceptibility of Staphylococcus aureus strain SG511 to antimicrobial peptides.

Sass Peter P   Bierbaum Gabriele G  

International journal of medical microbiology : IJMM 20090109 5


Staphylococcus aureus strain SG511-Berlin has been used as a standard strain for antimicrobial susceptibility testing and basic research since the first half of the last century. This study aimed at the identification of features of S. aureus SG511-Berlin that contribute to its high susceptibility to antimicrobial peptides (AMPs) in order to give insights into the mechanisms that S. aureus uses to counteract antimicrobials and to evaluate the role of S. aureus SG511-Berlin as a standard test str  ...[more]

Similar Datasets

2008-10-23 | GSE9261 | GEO
2008-01-01 | S-EPMC2592248 | BioStudies
2009-01-01 | S-EPMC2727956 | BioStudies
1999-01-01 | S-EPMC96381 | BioStudies
1999-01-01 | S-EPMC96736 | BioStudies
2002-01-01 | S-EPMC126572 | BioStudies
2016-01-01 | S-EPMC4773095 | BioStudies
2015-01-01 | S-EPMC4407209 | BioStudies
2003-01-01 | S-EPMC151770 | BioStudies
2016-01-01 | S-EPMC4704198 | BioStudies